Generate Biomedicines
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell GENB and other ETFs, options, and stocks.About GENB
Generate Biomedicines, Inc. is a clinical-stage generative biology company pioneering the AI revolution in biotechnology and drug design and development. The company was founded in 2018, and is headquartered in Somerville, MA.
GENB Key Statistics
Stock Snapshot
As of today, Generate Biomedicines(GENB) shares are valued at $16.44. The company's market cap stands at 2.11B.
As of 2026-07-01, Generate Biomedicines(GENB) stock has fluctuated between $16.18 and $17.14. The current price stands at $16.44, placing the stock +1.6% above today's low and -4.1% off the high.
The Generate Biomedicines(GENB)'s current trading volume is 361.31K, compared to an average daily volume of 1.48M.
In the last year, Generate Biomedicines(GENB) shares hit a 52-week high of $18.18 and a 52-week low of $11.00.
In the last year, Generate Biomedicines(GENB) shares hit a 52-week high of $18.18 and a 52-week low of $11.00.
Analyst ratings
100%
of 6 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.